^○Yebin D AHN¹, Dahyun YI², Haejung JOUNG¹, Eun Hyun SEO², Young Hwa LEE¹, Min soo BYUN³, Jun ho LEE¹, So Yeon JEON¹, Jun-Young LEE^{4, 5}, Bo Kyung SOHN⁶, Dong Young LEE^{1, 3, 5} (1. Department of Neuropsychiatry, Seoul National University Hospital, 2. Institute of Human Behavioral Medicine, Medical Research Center, Seoul National University, 3. Premedical Science, College of Medicine, Chosun University, 4. Department of Neuropsychiatry, SMG-SNU Boramae Medical Center, 5. Department of Psychiatry, Seoul National University College of Medicine, 6. Department of Psychiatry, Sanggye Paik Hospital, Inje University College of Medicine)

^○HANYONG JUNG¹, WOONG HAHM² (1. DEPARTMANT OF PSYCHIATRY, SOONCHUNHYANG UNIVERSITY BUCHEON , 2. KEYO MEDICAL CENTER)

^○Yasuhiro KANEDA¹, Koudai YOGI^{1, 2} (1. Department of Psychiatry, Iwaki Clinic, Anan, Japan, 2. Cancer Management Center Tokushima University Hospital, Tokushima, Japan)

^○Kohei OYABU¹, Hiroki KIYOTA¹, Kaori KUBOTA^{1, 2}, Takuya WATANABE^{1, 2}, Shutaro KATSURABAYASHI¹, Katsunori IWASAKI^{1, 2} (1. Department of Neuropharmacology, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan.　, 2. A.I.G. Collaborative Research Institute for Aging and Brain Sciences, Fukuoka University, Fukuoka, Japan.)

^○Na TAN, Yi WANG, Zhong CHEN (College of Pharmaceutical Sciences,Zhejiang University)